Literature DB >> 22508288

Recruitment mechanisms of primary and malignant B cells to the human liver.

Shishir Shetty1, Tony Bruns, Christopher J Weston, Zania Stamataki, Ye H Oo, Heather M Long, Gary M Reynolds, Guy Pratt, Paul Moss, Sirpa Jalkanen, Stefan G Hubscher, Patricia F Lalor, David H Adams.   

Abstract

UNLABELLED: B cells are present within chronically inflamed liver tissue and recent evidence implicates them in the progression of liver disease. In addition, a large proportion of hepatic lymphomas are of B-cell origin. The molecular signals that regulate normal and malignant B-cell recruitment into peripheral tissue from blood are poorly understood, leading us to study human B-cell migration through hepatic sinusoidal endothelial cells in flow-based adhesion assays. In such assays, human blood-derived B cells were captured from shear flow without a previous rolling phase and underwent firm adhesion mediated by vascular cell adhesion molecule-1 (VCAM-1). Unlike T cells, which displayed vigorous crawling behavior on the endothelium, B cells remained static before a proportion underwent transendothelial migration mediated by a combination of intercellular adhesion molecule-1 (ICAM-1), vascular adhesion protein-1, common lymphatic endothelial and vascular endothelial receptor-1/stabilin-1, and the chemokine receptors, CXCR3 and CXCR4. B-cell lymphoma cell lines and primary malignant B cells from patients with chronic lymphocytic leukemia and marginal zone B cell lymphoma also underwent integrin-mediated firm adhesion involving ICAM-1 and/or VCAM-1 and demonstrated ICAM-1-dependent shape-change and crawling behavior. Unlike primary lymphocytes, the malignant cells did not undergo transendothelial migration, which could explain why lymphomas are frequently characterized by the intravascular accumulation of malignant cells in the hepatic sinusoids.
CONCLUSION: Our findings demonstrate that distinct combinations of signals promote B-cell recruitment to the liver, suggesting the possibility of novel targets to modulate liver inflammation in disease. Certain features of lymphocyte homing are maintained in lymphoma recruitment to the liver, suggesting that therapeutic targets for lymphocyte recruitment may also prevent hepatic lymphoma dissemination.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22508288     DOI: 10.1002/hep.25790

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  24 in total

1.  Bregs in Chronic HBV: Is It Time for Bragging Rights?

Authors:  Nadia Alatrakchi
Journal:  Dig Dis Sci       Date:  2015-05       Impact factor: 3.199

2.  Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology.

Authors:  Mariana Silva; Ronald Kam Fai Fung; Conor Brian Donnelly; Paula Alexandra Videira; Robert Sackstein
Journal:  J Immunol       Date:  2017-03-22       Impact factor: 5.422

3.  Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.

Authors:  X Meng; N R Carlson; J Dong; Y Zhang
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

4.  Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

Authors:  Paul J Hampel; Kari G Chaffee; Rebecca L King; Douglas Simonetto; Melissa C Larson; Sara Achenbach; Timothy G Call; Wei Ding; Saad S Kenderian; Jose F Leis; Asher A Chanan-Khan; Deborah A Bowen; Michael J Conte; Susan M Schwager; Curtis A Hanson; Susan L Slager; Neil E Kay; Tait D Shanafelt; Sameer A Parikh
Journal:  Am J Hematol       Date:  2017-10-19       Impact factor: 10.047

5.  Follicular helper T cell and memory B cell immunity in CHC patients.

Authors:  Yong Liu; Huifan Ji; Pingwei Zhao; Hongqing Yan; Yanjun Cai; Lei Yu; Xiaoli Hu; Xiguang Sun; Yanfang Jiang
Journal:  J Mol Med (Berl)       Date:  2019-01-21       Impact factor: 4.599

6.  IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection.

Authors:  Abhishek Das; Gidon Ellis; Celeste Pallant; A Ross Lopes; Pooja Khanna; Dimitra Peppa; Antony Chen; Paul Blair; Geoffrey Dusheiko; Upkar Gill; Patrick T Kennedy; Maurizia Brunetto; Pietro Lampertico; Claudia Mauri; Mala K Maini
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

Review 7.  Vessel co-option in cancer.

Authors:  Elizabeth A Kuczynski; Peter B Vermeulen; Francesco Pezzella; Robert S Kerbel; Andrew R Reynolds
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

Review 8.  Crossing the Vascular Wall: Common and Unique Mechanisms Exploited by Different Leukocyte Subsets during Extravasation.

Authors:  Michael Schnoor; Pilar Alcaide; Mathieu-Benoit Voisin; Jaap D van Buul
Journal:  Mediators Inflamm       Date:  2015-10-19       Impact factor: 4.711

9.  Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis.

Authors:  Hannah C Jeffery; Manjit K Braitch; Chris Bagnall; James Hodson; Louisa E Jeffery; Rebecca E Wawman; Lin Lee Wong; Jane Birtwistle; Helen Bartlett; Ansgar W Lohse; Gideon M Hirschfield; Jessica Dyson; David Jones; Stefan G Hubscher; Paul Klenerman; David H Adams; Ye H Oo
Journal:  Hepatol Commun       Date:  2018-02-26

10.  SCARF-1 promotes adhesion of CD4+ T cells to human hepatic sinusoidal endothelium under conditions of shear stress.

Authors:  Daniel A Patten; Sivesh K Kamarajah; Joanne M Rose; Joseph Tickle; Emma L Shepherd; David H Adams; Chris J Weston; Shishir Shetty
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.